| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |